STANDARDIZATION OF CATIONIC DERIVATIVE OF BAKTERIOPURPURINIMID AS PHARMACEUTICAL SUBSTANCE FOR ANTIMICROBIAL PHOTODYNAMIC THERAPYA

Разработка и регистрация лекарственных средств

E. V. Vorfolomeeva¹  E. V. Feelonenko¹  M. A. Green¹  D. A. Grafov²  A. M. Frolova²  S. A. Kedeek³  N. A. Keryanov⁴  V. S. Tukova⁴  A. V. Panov⁴ 

[1] LLC «Institute of pharmaceutical technology»;D. Mendeleev University of Chemical Technology of Russia;P. Gercen scientific-research oncological institute of Moscow;Technological university of Moscow Limited company «Institute of pharmaceutical technology»;

关键词: standardization;    quality control;    pharmaceutical substance;    antimicrobial photodynamic therapy;    cationicderivative;    bakteriopurpurinimid;   

DOI  :  

来源: DOAJ

【 摘 要 】

In this paper key indicators due to Pharmacopoeia XIII [1] that can be used to standardize the cationic derivative of bakteriopurpurinimid as pharmaceutical substance (PS) are presented. The prime application of this compound to be a photosensitiser for antimicrobial photodynamic therapy (PDT).

【 授权许可】

Unknown